Literature DB >> 30745390

Role of Viscoelasticity in Bacterial Killing by Antimicrobials in Differently Grown Pseudomonas aeruginosa Biofilms.

René T Rozenbaum1, Henny C van der Mei1, Willem Woudstra1, Ed D de Jong1, Henk J Busscher1, Prashant K Sharma2.   

Abstract

Pseudomonas aeruginosa colonizes the sputum of most adult cystic fibrosis patients, forming difficult-to-eradicate biofilms in which bacteria are protected in their self-produced extracellular polymeric substance (EPS) matrices. EPS provide biofilms with viscoelastic properties, causing time-dependent relaxation after stress-induced deformation, according to multiple characteristic time constants. These time constants reflect different biofilm (matrix) components. Since the viscoelasticity of biofilms has been related to antimicrobial penetration but not yet bacterial killing, this study aims to relate killing of P. aeruginosa, in its biofilm mode of growth, by three antimicrobials to biofilm viscoelasticity. P. aeruginosa biofilms were grown for 18 h in a constant-depth film fermenter, with mucin-containing artificial sputum medium (ASM+), artificial sputum medium without mucin (ASM-), or Luria-Bertani (LB) broth; this yielded 100-μm-thick biofilms that differed in their amounts of matrix environmental DNA (eDNA) and polysaccharides. Low-load compression testing, followed by three-element Maxwell analyses, showed that the fastest relaxation component, associated with unbound water, was most important in LB-medium-grown biofilms. Slower components due to water with dissolved polysaccharides, insoluble polysaccharides, and eDNA were most important in the relaxation of ASM+-grown biofilms. ASM--grown biofilms showed intermediate stress relaxation. P. aeruginosa in LB-medium-grown biofilms was killed most by exposure to tobramycin, colistin, or an antimicrobial peptide, while ASM+ provided the most protective matrix, with less water and most insoluble polysaccharides and eDNA. In conclusion, stress relaxation of P. aeruginosa biofilms grown in different media revealed differences in matrix composition that, within the constraints of the antimicrobials and growth media applied, correlated with the matrix protection offered against different antimicrobials.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  Pseudomonas aeruginosazzm321990; biofilm; recalcitrance; viscoelasticity

Year:  2019        PMID: 30745390      PMCID: PMC6437498          DOI: 10.1128/AAC.01972-18

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  33 in total

1.  A microtiter modification of the anthrone-sulfuric acid colorimetric assay for glucose-based carbohydrates.

Authors:  Alexander Laurentin; Christine A Edwards
Journal:  Anal Biochem       Date:  2003-04-01       Impact factor: 3.365

2.  Quantification of biofilm structures by the novel computer program COMSTAT.

Authors:  A Heydorn; A T Nielsen; M Hentzer; C Sternberg; M Givskov; B K Ersbøll; S Molin
Journal:  Microbiology       Date:  2000-10       Impact factor: 2.777

Review 3.  The biofilm matrix.

Authors:  Hans-Curt Flemming; Jost Wingender
Journal:  Nat Rev Microbiol       Date:  2010-08-02       Impact factor: 60.633

Review 4.  Antimicrobial resistance, respiratory tract infections and role of biofilms in lung infections in cystic fibrosis patients.

Authors:  Oana Ciofu; Tim Tolker-Nielsen; Peter Østrup Jensen; Hengzhuang Wang; Niels Høiby
Journal:  Adv Drug Deliv Rev       Date:  2014-12-02       Impact factor: 15.470

5.  Gene expression of Pseudomonas aeruginosa in a mucin-containing synthetic growth medium mimicking cystic fibrosis lung sputum.

Authors:  Carina Fung; Sharna Naughton; Lynne Turnbull; Pholawat Tingpej; Barbara Rose; Jonathan Arthur; Honghua Hu; Christopher Harmer; Colin Harbour; Daniel J Hassett; Cynthia B Whitchurch; Jim Manos
Journal:  J Med Microbiol       Date:  2010-06-03       Impact factor: 2.472

Review 6.  Proteolytic regulation of alginate overproduction in Pseudomonas aeruginosa.

Authors:  F Heath Damron; Joanna B Goldberg
Journal:  Mol Microbiol       Date:  2012-04-13       Impact factor: 3.501

Review 7.  Alginate synthesis by Pseudomonas aeruginosa: a key pathogenic factor in chronic pulmonary infections of cystic fibrosis patients.

Authors:  T B May; D Shinabarger; R Maharaj; J Kato; L Chu; J D DeVault; S Roychoudhury; N A Zielinski; A Berry; R K Rothmel
Journal:  Clin Microbiol Rev       Date:  1991-04       Impact factor: 26.132

Review 8.  Viscoelasticity of biofilms and their recalcitrance to mechanical and chemical challenges.

Authors:  Brandon W Peterson; Yan He; Yijin Ren; Aidan Zerdoum; Matthew R Libera; Prashant K Sharma; Arie-Jan van Winkelhoff; Danielle Neut; Paul Stoodley; Henny C van der Mei; Henk J Busscher
Journal:  FEMS Microbiol Rev       Date:  2015-02-02       Impact factor: 16.408

Review 9.  Biofilms: microbial life on surfaces.

Authors:  Rodney M Donlan
Journal:  Emerg Infect Dis       Date:  2002-09       Impact factor: 6.883

10.  Stress relaxation analysis facilitates a quantitative approach towards antimicrobial penetration into biofilms.

Authors:  Yan He; Brandon W Peterson; Marije A Jongsma; Yijin Ren; Prashant K Sharma; Henk J Busscher; Henny C van der Mei
Journal:  PLoS One       Date:  2013-05-27       Impact factor: 3.240

View more
  10 in total

Review 1.  The biofilm matrix: multitasking in a shared space.

Authors:  Hans-Curt Flemming; Eric D van Hullebusch; Thomas R Neu; Per H Nielsen; Thomas Seviour; Paul Stoodley; Jost Wingender; Stefan Wuertz
Journal:  Nat Rev Microbiol       Date:  2022-09-20       Impact factor: 78.297

2.  The c-di-GMP Phosphodiesterase PipA (PA0285) Regulates Autoaggregation and Pf4 Bacteriophage Production in Pseudomonas aeruginosa PAO1.

Authors:  Yu-Ming Cai; Kai-Wei Yu; Ji-Hong Liu; Zhao Cai; Zun-Hao Zhou; Yang Liu; Tian-Fu Wang; Liang Yang
Journal:  Appl Environ Microbiol       Date:  2022-05-31       Impact factor: 5.005

3.  Activity of Antibiotics against Pseudomonas aeruginosa in an In Vitro Model of Biofilms in the Context of Cystic Fibrosis: Influence of the Culture Medium.

Authors:  Yvan Diaz Iglesias; Françoise Van Bambeke
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

Review 4.  Physics Comes to the Aid of Medicine-Clinically-Relevant Microorganisms through the Eyes of Atomic Force Microscope.

Authors:  Mateusz Cieśluk; Piotr Deptuła; Ewelina Piktel; Krzysztof Fiedoruk; Łukasz Suprewicz; Paulina Paprocka; Patrycja Kot; Katarzyna Pogoda; Robert Bucki
Journal:  Pathogens       Date:  2020-11-20

5.  The influence of time and irrigant refreshment on biofilm removal from lateral morphological features of simulated root canals.

Authors:  T C Pereira; R J B Dijkstra; X Petridis; W J van der Meer; P K Sharma; F B de Andrade; L W M van der Sluis
Journal:  Int Endod J       Date:  2020-08-27       Impact factor: 5.264

Review 6.  Biofilm mechanics: Implications in infection and survival.

Authors:  Erin S Gloag; Stefania Fabbri; Daniel J Wozniak; Paul Stoodley
Journal:  Biofilm       Date:  2019-12-19

Review 7.  NO donors and NO delivery methods for controlling biofilms in chronic lung infections.

Authors:  Yu-Ming Cai; Ying-Dan Zhang; Liang Yang
Journal:  Appl Microbiol Biotechnol       Date:  2021-05-03       Impact factor: 5.560

8.  Effects of Mucin and DNA Concentrations in Airway Mucus on Pseudomonas aeruginosa Biofilm Recalcitrance.

Authors:  Kaitlyn R Rouillard; William J Kissner; Matthew R Markovetz; David B Hill
Journal:  mSphere       Date:  2022-08-15       Impact factor: 5.029

9.  Chemical efficacy of several NaOCl concentrations on biofilms of different architecture: new insights on NaOCl working mechanisms.

Authors:  X Petridis; F H Busanello; M V R So; R J B Dijkstra; P K Sharma; L W M van der Sluis
Journal:  Int Endod J       Date:  2019-08-31       Impact factor: 5.264

10.  Magnetically driven active topography for long-term biofilm control.

Authors:  Huan Gu; Sang Won Lee; Joseph Carnicelli; Teng Zhang; Dacheng Ren
Journal:  Nat Commun       Date:  2020-05-05       Impact factor: 14.919

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.